LONDON (Thomson Financial) - Biopharmaceutical development company ValiRx
PLC said it has formed a strategic alliance with Bridgetech Holdings
International Inc to create and explore market and technology transfer
initiatives between Europe and China.
ValiRx chief executive Dr Satu Vainikka said the agreement with Bridgetech
will accelerate the process of taking knowledge generated in laboratories and
turning them into market-ready products.
TFN.newsdesk@thomson.com
pmi/tsm/slj
COPYRIGHT
Copyright AFX News Limited 2007. All rights reserved.
The copying, republication or redistribution of AFX News Content, including by
framing or similar means, is expressly prohibited without the prior written
consent of AFX News.
|